STAGE IV RENAL CELL CANCER AJCC V8
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo tested in rare, Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, could help control an aggressive and rare form of kidney cancer called renal medullary carcinoma. The trial involved 10 patients with advanced cancer that had spread or could not be surg…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo tested for Tough-to-Treat advanced cancers
Disease control TerminatedThis early-phase study tested the safety and effectiveness of adding a new drug called plinabulin to a combination of radiation and immunotherapy. It was for patients with advanced cancers (like lung, bladder, and melanoma) that had continued to grow despite prior immunotherapy. …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo aims to boost immune system against advanced kidney cancer before surgery
Disease control TerminatedThis study tested whether giving a drug called pembrolizumab, with or without another drug called axitinib, before and after surgery could help people with advanced kidney cancer. The goal was to see if this approach could better control the cancer and reduce the chance of it com…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested a two-drug combination for people with advanced kidney cancer (clear cell RCC) that had spread and worsened after they received standard treatments, including immunotherapy. The goal was to see if adding a pill called sitravatinib to an immunotherapy drug (nivol…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC